CANCER FINDING

A Yale Cancer Center study shows inhibition of the CECR2 gene prevents triplenegative breast cancer advancing or metastasising. The discovery could help find therapeutics for triple-negative breast cancer (TNBC), one of the most difficult sub-types to treat.